ICH E6 (R3) Guideline on good clinical practice (GCP)
International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use
GOOD CLINICAL PRACTICE (GCP) E6(R3) Step 5
23 January 2025. Date for coming into effect 23 July 2025
ICH E6(R3) introduces innovative provisions designed to apply across various types and settings of clinical trials, ensuring continued relevance in the face of ongoing technological and methodological advancements. This guideline provides a new language to facilitate innovations in clinical trial design, technology, and operational approaches. It encourages a risk-based and proportionate approach to conducting clinical trials, promoting fit-for-purpose solutions. It fosters transparency through clinical trial registration and result reporting and offers additional guidance to enhance the informed consent process.
The overarching principles and Annex 1, adopted by ICH and CHMP, came into effect on 23 July 2025.
With the public consultation now concluded, the Annex 2 is expected to be finalised later in 2025.
I. INTRODUCTION
II. PRINCIPLES OF ICH GCP
III. ANNEX 1
1. INSTITUTIONAL REVIEW BOARD/INDEPENDENT ETHICS COMMITTEE (IRB/IEC)
2. INVESTIGATOR
3. SPONSOR
4. DATA GOVERNANCE – INVESTIGATOR AND SPONSOR
Appendix A. INVESTIGATOR’S BROCHURE
Appendix B. CLINICAL TRIAL PROTOCOL AND PROTOCOL AMENDMENT(S)
Appendix C. ESSENTIAL RECORDS FOR THE CONDUCT OF A CLINICAL TRIAL
GLOSSARY
© European Medicines Agency, 2025. Reproduction is authorised provided the source is acknowledged.
Official address Domenico Scarlattilaan 6 ● 1083 HS Amsterdam ● The Netherlands
Address for visits and deliveries Refer to www.ema.europa.eu/how-to-find-us
Send a question Go to www.ema.europa.eu/contact Telephone +31 (0)88 781 6000
Clinical Research News
Upcoming Clinical Trials
-
Michigan State UniversityRecruiting
-
Second Affiliated Hospital, Zhejiang University...Not yet recruiting
-
Institute of Hematology & Blood Diseases Hospital...Not yet recruitingOxygen Deficiency | Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) | Graft FunctionChina
-
Centre Hospitalier Universitaire de NiceNot yet recruitingDystrophic Epidermolysis BullosaFrance
-
Université Catholique de LouvainFonds Spécial de Recherche (FSR), UCLouvainRecruitingAlcohol Use Disorder | Major Depressive Disorder (MDD)Belgium
-
Alexandria UniversityRecruiting
-
Tongji HospitalNot yet recruitingLiver Regeneration | Postoperative Liver Injury
-
Alexandria UniversityNot yet recruitingType 2 Diabetes MellitusEgypt
-
Lincoln University CollegeNot yet recruitingDental Trauma; Traumatic Dental Injury; Parent Education / Emergency Decision-Making
-
Zhihong LUNot yet recruiting
-
City of Hope Medical CenterNational Cancer Institute (NCI)Not yet recruitingHead and Neck Squamous Cell Carcinoma | Oropharyngeal Squamous Cell Carcinoma | Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Stage III Hypopharyngeal Carcinoma AJCC v8 | Stage III Laryngeal Cancer AJCC v8 | Stage III Oropharyngeal (p16-Negative) Carcinoma... and other conditionsUnited States
-
The First Affiliated Hospital of Soochow UniversityNot yet recruitingHematologic Malignancies | Acute Graft-Versus-Host Disease | Haploidentical Peripheral Blood Stem Cell Transplantation
Clinical Research Jobs
-
Italy - Milan
-
United States - Shrewsbury
-
United States - North Carolina - Durham
-
India - Kochi
-
United States - Massachusetts - Boston
-
India - Bengaluru
-
United States - North Carolina - Morrisville
-
China